Is your digital health startup or early-stage life sciences company aiming to...

Make scientific claims beyond safety and efficacy?

Develop the Research section on your website?

Educate investors on the burden of illness for the disease your product will treat?

Educate healthcare payers and providers on the unmet needs that your product will address?

Leverage real-world evidence (RWE) to support product commercialization?

Leverage economic evidence to support product commercialization?

Select examples of scientific claims derived from RWE

Pear Therapeutics: Digital therapeutic for substance use disorder

“Use of reSET-O is associated with significant and durable real-world reductions in ED and inpatient (including readmissions) utilization, reduced net costs, and increased clinician services and buprenorphine adherence. Differences in costs versus controls were greatest among Medicaid patients.”

Hinge Health: Online exercise therapy

“The largest-ever medical claims analysis of a digital MSK solution demonstrated that Hinge Health reduces medical claims by $2,387 per participant compared to a control group, delivering a 2.4x ROI.”

“Third-party analysis showed a 2.7x ROI for Medicare driven by reductions in medical-service use and annual healthcare savings.”

NOCD: Mobile application for obsessive compulsive disorder

“The total behavioral healthcare cost for the identified 4% of OCD members is approximately $12,276 per member, amounting to a behavioral health spend of $5.3 million annually. The total cost of care for the remaining OCD population (the hidden 96%) is roughly $8,600 per member†, amounting to $98.9 million in behavioral health spend, much of which is paying for inappropriate or otherwise wasteful care.”

“Summing up the total OCD population, including identified and submerged (hidden) members, reveals payers are spending about $104.2 million per year per one million members, or $8.69 PMPM*—all to achieve suboptimal outcomes in many cases.”

Best practices

Pear Therapeutics: Digital therapeutic for substance use disorder

Generation of RWE to support real-world effectiveness of reSET

Dedicated health economics and outcomes research (HEOR) lead

Mahana Therapeutics

AMCP dossier (product information on efficacy, safety, economic benefits) available upon request

Dedicated market access team (access@mahana.com)

Publications section on website to support key messages on unmet needs, burden of illness, and potential product benefits

Perfuze: Clot removal device

Unmet Clinical Need section on website

Zerigo Health: Smart light therapy device for psoriasis and eczema

Employers and Health Plans section on website

Interactive budget impact model on website

EBT Medical: Noninvasive neuromodulation assistant for overactive bladder

Patient preference data on website

Comparison table for product vs competitive therapies

Sera Prognostics

"PreTRM for Payers" section on website with data on prevalence, morbidity, mortality, and economic impacts

Let's work together and create something great. Artistic. Unique. Impactful.

My name is Justin Yu and I am an independent consultant specializing in the use of health economics and outcomes research (HEOR) and real-world evidence (RWE) to support the launch, uptake, and reimbursement of innovative products.

Why work with me? I specialize in providing strategic advise to startup and early-stage digital health/life science companies. My goal is to provide you with HEOR support before you need to hire a full-time HEOR/RWE lead. I consider my work a hobby. Your success is my success.

Contact Information